DBV Technologies S.A. DBVT
Regular-session close
After hours · Nov 20, 4:00 PM ET
- YTD
- -52.95%
- 1 year
- -34.50%
Held by funds
3 US ETFs and mutual funds hold DBVT · largest positions
Ownership
- Institutions 37.2%
- Insiders 0.00%
- Public and other holders 62.8%
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| MPM Bioimpact LLC | 8.80% | 5,213,361 | 90.45M | Mar 30, 2026 |
| Vivo Capital, LLC | 4.51% | 2,667,569 | 46.28M | Mar 30, 2026 |
| Artisan Partners Limited Partnership | 3.75% | 2,219,386 | 38.51M | Mar 30, 2026 |
| Siren, L.L.C. | 3.14% | 1,857,362 | 32.23M | Mar 30, 2026 |
| Baker Bros. Advisors, LP | 2.47% | 1,461,425 | 25.36M | Mar 30, 2026 |
| Adar1 Capital Management, LLC | 1.71% | 1,012,866 | 17.57M | Mar 30, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Artisan Partners Funds Inc.-Artisan International Small-Mid Fund | 2.30% | 1,363,189 | 23.65M | Mar 30, 2026 |
| RUSSELL INVESTMENT CO-Tax-Managed U.S. Mid & Small Cap Fund | 0.08% | 45,089 | 782.29K | Apr 29, 2026 |
| AdvisorShares Trust-AdvisorShares Dorsey Wright ADR ETF | 0.07% | 44,095 | 765.05K | May 30, 2026 |
| RUSSELL INVESTMENT CO-U.S. Small Cap Equity Fund | 0.04% | 22,707 | 393.97K | Apr 29, 2026 |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 0.02% | 8,897 | 154.36K | May 30, 2026 |
| RUSSELL INVESTMENT FUNDS-U.S. Small Cap Equity Fund | 0.01% | 5,834 | 101.22K | Mar 30, 2026 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Leadership team
Who runs DBVT, and what each was last paid
Daniel Tassé, Chief Executive Officer & DirectorAverage age 63
| Name | Title | Pay | Age |
|---|---|---|---|
| Daniel Tassé | Chief Executive Officer & Director | $1.44M | 66 |
| Pharis Mohideen | Chief Medical Officer | $1.02M | 61 |
| Virginie Simone Jeanine Verrechia Boucinha | Chief Financial Officer | $600K | 57 |
| Alan Kerr | Senior Vice President & Head of Global Regulatory Affairs | — | — |
| Kevin Malobisky | Chief Operations Officer | — | — |
| Robert G. Pietrusko D. | Chief Regulatory Officer | — | 78 |
| James Briggs | Chief Human Resources Officer | — | 54 |
| Jonathan Neely | VP & Head of Investor Relations | — | — |
| Kevin Trapp | Chief Commercial Officer | — | 59 |
| Pascal Wotling | Chief External Manufacturing & Supply Chain Officer | — | — |
| Michele F. Robertson | Chief Legal Officer | — | — |
Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| MOHIDEEN PHARIS | Officer | Sale | Jan 28, 2026 | 144,995 |
